Cargando…
Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours
Pituitary neuroendocrine tumours (PitNETs) associated with paragangliomas or phaeochromocytomas are rare. SDHx variants are estimated to be associated with 0.3–1.8% of PitNETs. Only a few case reports have documented the association with MAX variants. Prolactinomas are the most common PitNETs occurr...
Autores principales: | Loughrey, Paul Benjamin, Roncaroli, Federico, Healy, Estelle, Weir, Philip, Basetti, Madhu, Casey, Ruth T, Hunter, Steven J, Korbonits, Márta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513646/ https://www.ncbi.nlm.nih.gov/pubmed/35938916 http://dx.doi.org/10.1530/ERC-22-0157 |
Ejemplares similares
-
Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas
por: Gill, Anthony J., et al.
Publicado: (2014) -
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
por: Marques, Pedro, et al.
Publicado: (2019) -
Clinical and Pathological Aspects of Silent Pituitary Adenomas
por: Drummond, Juliana, et al.
Publicado: (2018) -
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019) -
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
por: Trouillas, Jacqueline, et al.
Publicado: (2020)